Knickerbocker Dialysis, Inc in Corning, New York - Dialysis Center

Knickerbocker Dialysis, Inc is a medicare approved dialysis facility center in Corning, New York and it has 10 dialysis stations. It is located in Steuben county at 8 West Pultney Street, Corning, NY, 14830. You can reach out to the office of Knickerbocker Dialysis, Inc at (607) 962-2790. This dialysis clinic is managed and/or owned by Davita. Knickerbocker Dialysis, Inc has the following ownership type - Profit. It was first certified by medicare in October, 1999. The medicare id for this facility is 332732 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameKnickerbocker Dialysis, Inc
Location8 West Pultney Street, Corning, New York
No. of Dialysis Stations 10
Medicare ID332732
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


8 West Pultney Street, Corning, New York, 14830
(607) 962-2790

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Knickerbocker Dialysis, Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1982088449
Organization NameCorning Dilaysis
Doing Business AsKnickerbocker Dialysis Inc
Address8 W Pulteney St Corning, New York, 14830
Phone Number(607) 962-2790

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data29
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL17

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center52
    Adult patient months included in Kt/V greater than or equal to 1.2446
    Percentage of adult patients getting regular hemodialysis at the center96
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Actavis seeks FDA approval to market generic version of Quillivant XR

    Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

    New study highlights gap in postpartum blood pressure screening

    In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

    Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

    For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

    Medical errors: The third cause of death in the US

    New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

    Read more Medical News

    › Verified 2 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Knickerbocker Dialysis, Inc with elevated calcium levels.

Patients with hypercalcemia52
Hypercalcemia patient months446
Patients with Serumphosphor54
Patients with Serumphosphor less than 3.5 mg/dL12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL34
Patients with Serumphosphor from 5.6 to 7 mg/dL20
Patients with Serumphosphor greater than 7 mg/dL7

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 42
Patient months included in arterial venous fistula and catheter summaries 348
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment55
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer24

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary43
Hospitalization Rate in facility253.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit443.4
Hospitalization Rate: Lower Confidence Limit150.9

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Knickerbocker Dialysis, Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility27.1 (As Expected)
Readmission Rate: Upper Confidence Limit39
Readmission Rate: Lower Confidence Limit17

News Archive

Actavis seeks FDA approval to market generic version of Quillivant XR

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

New study highlights gap in postpartum blood pressure screening

In a new study, only 13.7% of women diagnosed with hypertensive disorders of pregnancy (HDP) attended a blood pressure screening visit within 10 days of delivery. HDP can cause life-threatening complications, as described in the study published in the peer-reviewed Journal of Women's Health.

Study examines outcomes of open and robotic partial nephrectomy in patients with kidney tumors

For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.

Medical errors: The third cause of death in the US

New research estimates up to 440,000 Americans are dying annually from preventable hospital errors. This puts medical errors as the third leading cause of death in the United States, underscoring the need for patients to protect themselves and their families from harm, and for hospitals to make patient safety a priority.

Read more Medical News

› Verified 2 days ago